RING CHRISTINE (General Counsel) sold 19.1% of their position (8.15K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $125.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001817199-26-000010
Officer· General Counsel
Since Jul 2020
-8.15K
Net shares
Net seller
$125.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.15K
Price / share
$15.44
Trade value
$125.79K
% of position
19.1%
3/2/2026
42.75K→34.60K
Total
Net shares
−8.15K
Net value
-$125.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −8.15K | $15.44 | $125.79K | 19.1% | 42.75K | 34.60K |
| Total | −8.15K | -$125.79K | ||||||
Derivative Transactions0
No derivative transactions reported